Panacea Biotec Share Price
383.20-5.85 (-1.50%)
-9.58% past 1 Year
News
Panacea Biotec secures Rs 78.24 crores UNICEF polio vaccine supply award
Equity
PANACEABIO
Panacea Biotec files appeal against fourth industrial tribunal award, court grants interim relief
Equity
PANACEABIO
Panacea Biotec partners Denstar Project to expand dengue vaccine licensing in Africa
Equity
PANACEABIO
Panacea Biotec Receives CMSS Award Letter for Rs 20.79 Crore Td Vaccine Supply Contract.
Equity
PANACEABIO
Panacea Biotec Tribunal Order Cancels Rs 329 Crore Tax Demand
Equity
PANACEABIO
Panacea Biotec Reports Strong Q3 EBITDA Growth to Rs 11.70 Crores, Margin at 7.11% YoY.
Equity
PANACEABIO
Panacea Biotec Q3FY26 Earnings: Revenue Up YoY, Net Profit Slightly Down.
Equity
PANACEABIO
NCPHP Issues Non-Compliance Notice to Panacea Biotec; GMP Certifications Revoked
Equity
PANACEABIO
Panacea Biotec completes Phase III trial enrolment for DengiAll dengue vaccine, eyes 2027 launch.
Equity
PANACEABIO
Panacea Biotec Completes Enrollment of 10,335 Participants in Phase III Dengue Vaccine DengiAll Trial.
Equity
PANACEABIO
Panacea Biotec Secures UNICEF Contract Enhancement Boosting Vaccine Supply Value by $8.93 Million for 2026-2027.
Equity
PANACEABIO
Devender Gupta, CFO and Head IT, resigns from Panacea Biotec effective December 15, 2025
Equity
PANACEABIO
Panacea Biotec Reports Q2 EBITDA Loss of 17.80 Crores
Equity
PANACEABIO
Panacea Biotec Q2 FY26 results: Net loss widens, revenue declines year-on-year.
Equity
PANACEABIO
Panacea Biotec secures Rs 39.57 crore order for Easyfive-TT vaccine supply in 2026-2027
Equity
PANACEABIO
Panacea Biotec files counterclaims in USD 70 lakh arbitration over COVID-19 tech transfer at LCIA
Equity
PANACEABIO
Panacea Biotec secures Rs 127.20 crore contract for polio vaccine supply to CMSS
Equity
PANACEABIO
Panacea Biotec: Co'S Wholly-Owned Subsidiary, Panacea Biotec Pharma Ltd., Launches India’S First 100% Toxin-Free Baby Care Line “Nikomom” And Infant Milk Substitute “Staart Prime” For The Domestic Market
Equity
PANACEABIO
Panacea Biotec: Co Has Exceptional Item Of 11.30 Crores Rupees || Q1 Loss Before Tax 4.80 Crores Rupees Vs Loss 19.80 Crores (Yoy)
Equity
PANACEABIO
Panacea Biotec: Q1 Cons Net Profit 4.10 Crores Rupees Vs Loss 15.80 Crores (Yoy) || Q1 Revenue 170.00 Crores Rupees Vs 116.00 Crores (Yoy)
Equity
PANACEABIO